Stockscreener 앱 받기
0.0793
4.76%
0.0036
시간 외 거래:
.07
-0.0093
-11.73%
전일 마감가:
$0.0757
열려 있는:
$0.0737
하루 거래량:
5.59M
Relative Volume:
0.51
시가총액:
$1.10M
수익:
-
순이익/손실:
$-53.12M
주가수익비율:
-0.000729
EPS:
-108.8
순현금흐름:
$-15.86M
1주 성능:
-25.19%
1개월 성능:
-67.95%
6개월 성능:
-98.28%
1년 성능:
-98.72%
1일 변동 폭
$0.0728
$0.084
1주일 범위
$0.065
$0.1496
52주 변동 폭
$0.065
$21.40
블루 워터 백신 Stock (ONCO) Company Profile
명칭
Onconetix Inc
전화
513-620-4101
주소
201 E. FIFTH STREET, CINCINNATI
ONCO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
0.0793 | 1.10M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
블루 워터 백신 주식(ONCO)의 최신 뉴스
Onconetix Delays Yearly Report Filing - TipRanks
Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews
Onconetix claims validation of prostate cancer test Proclarix in Danish cohort - Yahoo Finance
Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort - GlobeNewswire
Onconetix reveals Proclarix’s clinical performance at EAU congress - Investing.com India
Onconetix Announces Successful Clinical Validation Of Proclarix For Prostate Cancer In Danish Cohort - Nasdaq
Onconetix reveals Proclarix’s clinical performance at EAU congress By Investing.com - Investing.com South Africa
Onconetix Inc. Presents Promising Clinical Data for Proclarix® at 2025 EAU Congress - Nasdaq
Revolutionary Prostate Cancer Test Cuts Unnecessary Biopsies by 22%, Shows 96% Detection Rate - Stock Titan
Onconetix Inc (NASDAQ: ONCO): Blank Check On Growth? - Stocks Register
Onconetix Announces New Clinical Data for its Innovative - GlobeNewswire
Onconetix to Present Proclarix at EAU Congress 2025 - TipRanks
Onconetix, Inc. to Present Proclarix Study Results at 2025 EAU Congress in Madrid - Nasdaq
Groundbreaking 800-Patient Study Shows How Onconetix's Proclarix Test Prevents Unnecessary Prostate Biopsies - StockTitan
ONCO stock plunges to 52-week low, touches $0.12 By Investing.com - Investing.com Australia
ONCO stock plunges to 52-week low, touches $0.12 - Investing.com India
Onconetix taps industry veteran as executive chairman amid CEO resignation - The Business Journals
Onconetix names new executive chairman, appoints board member By Investing.com - Investing.com Australia
Onconetix names new executive chairman, appoints board member - Investing.com India
Onconetix Announces Leadership Changes and New Appointments - TipRanks
Onconetix Says Ralph Schiess Resigns As Interim CEO And Chief Science Officer -February 28, 2025 at 05:35 pm EST - Marketscreener.com
Onconetix secures new financing, appoints auditor, sees executive exit By Investing.com - Investing.com South Africa
Onconetix secures new financing, appoints auditor, sees executive exit - Investing.com
Onconetix Announces Promissory Note Agreement with Keystone - TipRanks
Investing in Onconetix Inc (ONCO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Onconetix Inc (ONCO) Stock: A Year of Decreases and Increases - The InvestChronicle
Daily Market Movement: Onconetix Inc (ONCO) Sees a 11.91 Increase, Closing at 0.61 - The Dwinnex
Onconetix files to sell 50M shares of common stock for holders - MSN
Stock market today: Allakos dropped by 76.37% whereas Onconetix jumped by 77.10% in early trading - Business Upturn
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Onconetix faces Nasdaq delisting over share price rule - MSN
Onconetix faces Nasdaq delisting over share price rule By Investing.com - Investing.com Nigeria
Onconetix settles with IQVIA, adjusts accounts payable - MSN
Onconetix settles with IQVIA, adjusts accounts payable By Investing.com - Investing.com Canada
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet - Benzinga
ONCO Stock Plummets to 52-Week Low at $0.37 Amid Market Struggles By Investing.com - Investing.com South Africa
Onconetix files overdue quarterly report, addresses Nasdaq notice By Investing.com - Investing.com South Africa
Onconetix files overdue quarterly report, addresses Nasdaq notice - Investing.com
Onconetix, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewswire
Onconetix Resolves Nasdaq Compliance Issue After Late Q3 Filing - StockTitan
ONCO stock touches 52-week low at $0.58 amid market challenges - Investing.com India
Onconetix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Onconetix Inc. (ONCO) reports earnings - Quartz
Onconetix amends forbearance agreement with Veru Inc. - Investing.com
ONCO Stock Hits 52-Week Low at $0.6 Amid Market Challenges - Investing.com Nigeria
블루 워터 백신 (ONCO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.00%
자본화:
|
볼륨(24시간):